Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 14,969 | 802 | 44,703 | 268 | 4,821 |
| Gross Profit | 14,969 | 802 | 44,703 | 268 | 4,821 |
| Operating Expenses | 82,939 | 84,716 | 48,744 | 45,489 | 24,867 |
| Operating Income | -67,970 | -83,914 | -4,041 | -45,221 | -20,046 |
| Interest Expense | 53 | 28 | 19 | 2,668 | 3,600 |
| Other Income | 6,796 | 7,420 | 4,910 | -3,251 | 5,808 |
| Pre-tax Income | -61,227 | -76,522 | 850 | -51,140 | -17,838 |
| Income Tax | -44 | -3,075 | -4,471 | -28 | 95 |
| Net Income Continuous | -61,183 | -73,447 | 5,321 | -51,112 | -17,933 |
| Minority Interests | -109 | -100 | -21 | -247 | -227 |
| Net Income | $-61,074 | $-73,347 | $5,342 | $-50,865 | $-17,706 |
| EPS Basic Total Ops | -1.55 | -1.91 | 0.14 | -1.96 | -2.24 |
| EPS Basic Continuous Ops | -1.55 | -1.91 | 0.14 | -1.97 | -2.27 |
| EPS Diluted Total Ops | -1.55 | -1.91 | 0.14 | -1.96 | -2.24 |
| EPS Diluted Continuous Ops | -1.55 | -1.91 | 0.14 | -1.97 | -2.27 |
| EPS Diluted Before Non-Recurring Items | -1.55 | -1.91 | 0.14 | -1.67 | N/A |
| EBITDA(a) | $-62,170 | $-78,485 | $282 | $-44,619 | $-19,838 |